vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and MP Materials Corp. (MP). Click either name above to swap in a different company.

MP Materials Corp. is the larger business by last-quarter revenue ($52.7M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). MP Materials Corp. runs the higher net margin — 17.9% vs -19.9%, a 37.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -13.6%). AbCellera Biologics Inc. produced more free cash flow last quarter ($-44.6M vs $-109.3M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 4.0%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

MP Materials Corp. is a U.S.-based producer of rare earth materials. The company owns and operates the Mountain Pass mine in California, the only active rare earth mining and processing facility in the Western Hemisphere, producing essential materials for electric vehicles, wind turbines, and defense applications.

ABCL vs MP — Head-to-Head

Bigger by revenue
MP
MP
1.2× larger
MP
$52.7M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+802.0% gap
ABCL
788.4%
-13.6%
MP
Higher net margin
MP
MP
37.8% more per $
MP
17.9%
-19.9%
ABCL
More free cash flow
ABCL
ABCL
$64.7M more FCF
ABCL
$-44.6M
$-109.3M
MP
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
4.0%
MP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
MP
MP
Revenue
$44.9M
$52.7M
Net Profit
$-8.9M
$9.4M
Gross Margin
Operating Margin
-63.7%
-7.0%
Net Margin
-19.9%
17.9%
Revenue YoY
788.4%
-13.6%
Net Profit YoY
73.9%
142.2%
EPS (diluted)
$-0.03
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
MP
MP
Q4 25
$44.9M
$52.7M
Q3 25
$9.0M
$53.6M
Q2 25
$17.1M
$57.4M
Q1 25
$4.2M
$60.8M
Q4 24
$5.0M
$61.0M
Q3 24
$6.5M
$62.9M
Q2 24
$7.3M
$31.3M
Q1 24
$10.0M
$48.7M
Net Profit
ABCL
ABCL
MP
MP
Q4 25
$-8.9M
$9.4M
Q3 25
$-57.1M
$-41.8M
Q2 25
$-34.7M
$-30.9M
Q1 25
$-45.6M
$-22.6M
Q4 24
$-22.3M
Q3 24
$-51.1M
$-25.5M
Q2 24
$-36.9M
$-34.1M
Q1 24
$-40.6M
$16.5M
Operating Margin
ABCL
ABCL
MP
MP
Q4 25
-63.7%
-7.0%
Q3 25
-851.8%
-125.2%
Q2 25
-290.2%
-76.5%
Q1 25
-1479.6%
-57.2%
Q4 24
-72.1%
Q3 24
-1439.4%
-62.8%
Q2 24
-1276.2%
-171.1%
Q1 24
-551.5%
-66.6%
Net Margin
ABCL
ABCL
MP
MP
Q4 25
-19.9%
17.9%
Q3 25
-637.8%
-78.0%
Q2 25
-203.3%
-53.8%
Q1 25
-1077.2%
-37.2%
Q4 24
-36.6%
Q3 24
-785.4%
-40.5%
Q2 24
-504.3%
-108.9%
Q1 24
-408.0%
33.9%
EPS (diluted)
ABCL
ABCL
MP
MP
Q4 25
$-0.03
$0.07
Q3 25
$-0.19
$-0.24
Q2 25
$-0.12
$-0.19
Q1 25
$-0.15
$-0.14
Q4 24
$-0.12
Q3 24
$-0.17
$-0.16
Q2 24
$-0.13
$-0.21
Q1 24
$-0.14
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
MP
MP
Cash + ST InvestmentsLiquidity on hand
$128.5M
$1.2B
Total DebtLower is stronger
$998.7M
Stockholders' EquityBook value
$966.9M
$2.0B
Total Assets
$1.4B
$3.9B
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
MP
MP
Q4 25
$128.5M
$1.2B
Q3 25
$83.2M
$1.1B
Q2 25
$92.4M
$261.5M
Q1 25
$159.3M
$198.3M
Q4 24
$156.3M
$282.4M
Q3 24
$126.6M
$284.4M
Q2 24
$148.3M
$295.6M
Q1 24
$123.6M
$296.5M
Total Debt
ABCL
ABCL
MP
MP
Q4 25
$998.7M
Q3 25
$997.3M
Q2 25
$910.8M
Q1 25
$909.8M
Q4 24
$908.7M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ABCL
ABCL
MP
MP
Q4 25
$966.9M
$2.0B
Q3 25
$964.0M
$2.0B
Q2 25
$1.0B
$1.0B
Q1 25
$1.0B
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$1.1B
Q2 24
$1.1B
$1.1B
Q1 24
$1.1B
$1.1B
Total Assets
ABCL
ABCL
MP
MP
Q4 25
$1.4B
$3.9B
Q3 25
$1.4B
$3.8B
Q2 25
$1.4B
$2.3B
Q1 25
$1.3B
$2.4B
Q4 24
$1.4B
$2.3B
Q3 24
$1.4B
$2.3B
Q2 24
$1.4B
$2.4B
Q1 24
$1.5B
$2.4B
Debt / Equity
ABCL
ABCL
MP
MP
Q4 25
0.50×
Q3 25
0.51×
Q2 25
0.90×
Q1 25
0.88×
Q4 24
0.86×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
MP
MP
Operating Cash FlowLast quarter
$-34.7M
$-46.9M
Free Cash FlowOCF − Capex
$-44.6M
$-109.3M
FCF MarginFCF / Revenue
-99.4%
-207.4%
Capex IntensityCapex / Revenue
21.9%
118.5%
Cash ConversionOCF / Net Profit
-4.97×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$-328.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
MP
MP
Q4 25
$-34.7M
$-46.9M
Q3 25
$-52.6M
$-42.0M
Q2 25
$-32.4M
$-3.7M
Q1 25
$-11.6M
$-63.2M
Q4 24
$-108.6M
$30.5M
Q3 24
$-28.9M
$-6.8M
Q2 24
$-30.0M
$30.8M
Q1 24
$-41.7M
$-41.1M
Free Cash Flow
ABCL
ABCL
MP
MP
Q4 25
$-44.6M
$-109.3M
Q3 25
$-61.5M
$-92.5M
Q2 25
$-45.8M
$-32.7M
Q1 25
$-22.2M
$-93.7M
Q4 24
$-187.0M
$-11.2M
Q3 24
$-47.4M
$-53.3M
Q2 24
$-50.1M
$-15.6M
Q1 24
$-65.8M
$-93.0M
FCF Margin
ABCL
ABCL
MP
MP
Q4 25
-99.4%
-207.4%
Q3 25
-687.0%
-172.8%
Q2 25
-267.9%
-56.9%
Q1 25
-524.0%
-154.0%
Q4 24
-3702.8%
-18.3%
Q3 24
-728.4%
-84.7%
Q2 24
-683.8%
-50.1%
Q1 24
-661.5%
-191.0%
Capex Intensity
ABCL
ABCL
MP
MP
Q4 25
21.9%
118.5%
Q3 25
99.7%
94.3%
Q2 25
78.2%
50.5%
Q1 25
251.1%
50.1%
Q4 24
1552.7%
68.3%
Q3 24
284.6%
73.8%
Q2 24
274.6%
148.7%
Q1 24
242.5%
106.5%
Cash Conversion
ABCL
ABCL
MP
MP
Q4 25
-4.97×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

MP
MP

Materials Segment$35.6M68%
Other$17.1M32%

Related Comparisons